The impact of a disease management programme including a supervised exercise programme versus disease management alone on death, readmissions, depression and functional status in patients with a recent hospitalisation for heart failure

Associate Professor Alison Mudge0 个研究点目标入组 360 人开始时间: 2008年5月23日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Less than or equal to 6 weeks post acute admission to hospital with symptomatic congestive heart failure as dominant clinical diagnosis. Evidence during admission of clinically significant criteria: including documented symptoms (dyspnoea, fatigue, and/or peripheral oedema) and signs (raised jugular venous pressure, displaced apex beat, 3rd heart sound, and/or crepitations on chest examination). Chest xray changes (pulmonary venous congestion, pulmonary oedema and cardiomegaly) or current/past echocardiography evidence of left ventricular dysfunction. Echocardiography within 6 months. On medical therapy for heart failure. Able to regularly attend the duration of the programme and all follow-ups. Satisfy safety criteria; Signed written informed consent; Aged 18 years or older.

•Terminally ill. Serious cognitive impairment. Serious other physical impairment which prevents attendance and participation. Implantable cardioverter defibrillator insertion < 4 weeks preceding programme. Cardiac re-synchonisation therapy < 6 months preceding programme. Awaiting cardiovascular procedure or hospitalisation for surgery. Exercise testing results or clinical judgement by the exercise specialist that would preclude safe exercise training participation. Completed a full 12 week regime of formal exercise rehabilitation in the past 12 month period.

发起方

Associate Professor Alison Mudge